First-pass extracted concept

ocular gene therapy

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

Gene therapy has emerged as a promising approach, offering the potential for durable and curative outcomes through precise genetic manipulation.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2025MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1future directionsupports2025Source 1DOI PubMed

Future ocular gene therapy development is expected to include prime editing, miRNA-based regulation, and combinatorial approaches with stem cell transplantation or neuroprotective agents.

Claim 2limitation summarysupports2025Source 1DOI PubMed

Ocular gene therapy still faces challenges including immune responses to viral vectors, limited transduction efficiency in certain cell types, and anatomical barriers from the blood-retinal barrier.

Claim 3review summarysupports2025Source 1DOI PubMed

Gene therapy is presented as a promising approach for posterior segment eye diseases because it offers potential durable and curative outcomes through precise genetic manipulation.